- Home
- TLSI vs HFFG Comparison
TLSI vs HFFG Comparison
Compare TLSI & HFFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- HFFG
- Stock Information
- Founded
- TLSI 2010
- HFFG N/A
- Country
- TLSI United States
- HFFG United States
- Employees
- TLSI N/A
- HFFG N/A
- Industry
- TLSI Medical Specialities
- HFFG Food Distributors
- Sector
- TLSI Health Care
- HFFG Consumer Discretionary
- Exchange
- TLSI Nasdaq
- HFFG Nasdaq
- Market Cap
- TLSI 166.8M
- HFFG 162.4M
- IPO Year
- TLSI N/A
- HFFG N/A
- Fundamental
- Price
- TLSI $4.76
- HFFG $3.53
- Analyst Decision
- TLSI Strong Buy
- HFFG
- Analyst Count
- TLSI 3
- HFFG 0
- Target Price
- TLSI $12.67
- HFFG N/A
- AVG Volume (30 Days)
- TLSI 65.5K
- HFFG 33.4K
- Earning Date
- TLSI 11-12-2024
- HFFG 11-07-2024
- Dividend Yield
- TLSI N/A
- HFFG N/A
- EPS Growth
- TLSI N/A
- HFFG N/A
- EPS
- TLSI N/A
- HFFG 0.07
- Revenue
- TLSI $24,736,000.00
- HFFG $1,160,322,000.00
- Revenue This Year
- TLSI $61.24
- HFFG N/A
- Revenue Next Year
- TLSI $47.32
- HFFG N/A
- P/E Ratio
- TLSI N/A
- HFFG $47.13
- Revenue Growth
- TLSI 67.75
- HFFG N/A
- 52 Week Low
- TLSI $3.32
- HFFG $2.46
- 52 Week High
- TLSI $10.42
- HFFG $5.91
- Technical
- Relative Strength Index (RSI)
- TLSI 38.74
- HFFG 57.17
- Support Level
- TLSI $4.43
- HFFG $3.02
- Resistance Level
- TLSI $5.32
- HFFG $3.31
- Average True Range (ATR)
- TLSI 0.37
- HFFG 0.21
- MACD
- TLSI -0.04
- HFFG 0.02
- Stochastic Oscillator
- TLSI 27.24
- HFFG 82.26
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About HFFG HF Foods Group Inc.
HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The Company's business consists of one operating segment; HF Group, which operates solely in the United States. The Company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.